Source: International Congress 2014 – PG02 Current clinical problems in pulmonology



Rating:

Share or cite this content

Citations should be made in the following way:
P. Camus (Dijon, France). To be or not to be–could it be drug related pulmonary disease?. International Congress 2014 – PG02 Current clinical problems in pulmonology

Member's Comments

No comment yet.

Related content which might interest you: Occupational COPD : what is new and how do we identify and ultimately prevent this disease? Source: International Congress 2019 – PG13 Traditional and modern clinical approaches for diagnosis and management of occupational airways diseases Year: 2019 How we can modify the steroid insensitivity in patients with chronic obstructive pulmonary disease? The new pharmacological approach to old problem Source: Annual Congress 2011 - COPD management Year: 2011 Is a degree of asthma therapy related to pulmonary function impairment? Source: Eur Respir J 2001; 18: Suppl. 33, 41s Year: 2001 Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021 Year: 2021 Treatment of early lung disease – is it possible? Does it work? Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early Year: 2004 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Opportunist mycobacterial lung disease - which drug combination is more effective? Source: Breathe 2009; 6: 67-69 Year: 2009 Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension? Source: Eur Respir J 2014; 44: 842-845 Year: 2014 What are the common biological mechanisms that lead to obstructive airway disease? Source: International Congress 2016 – Early life origins of asthma and COPD Year: 2016 TB following targeted and biological therapy: can we predict it? Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 How does inflammation contribute to pulmonary hypertension? Source: Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017 Year: 2018 Self-efficacy. Does it change as a result of pulmonary rehabilitation? A pilot study Source: Annual Congress 2006 - Effective strategies for chronic respiratory patient management Year: 2006 Rare pulmonary disease and orphan drugs: a path to the future Source: Eur Respir Rev, 28 (153) 190115; 10.1183/16000617.0115-2019 Year: 2019 What are the factors related to misdiagnosis of COPD? Source: Annual Congress 2011 - COPD management Year: 2011 Combined emphysema & interstitial pulmonary disease. A new disease entity? Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002 Dismantling airway disease with the use of new pulmonary function indices Source: Eur Respir Rev, 28 (151) 180122; 10.1183/16000617.0122-2018 Year: 2019 Does lung function predict response to therapy in PAH associated with connective tissue disease? Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012